BBC Homepage World Service Education
BBC Homepagelow graphics version | feedback | help
BBC News Online
 You are in: Health
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Background Briefings 
Medical notes 
Education 
Entertainment 
Talking Point 
In Depth 
AudioVideo 


The BBC's Fergus Walsh
"Experts expect the survival rates to keep improving rapidly"
 real 28k

Prof Sir Richard Peto and Prof Jonathan Waxman
argue the success of British cancer care
 real 28k

Friday, 19 May, 2000, 10:00 GMT 11:00 UK
Breast cancer deaths plummet
mammogram
Early detection has saved lives
An unprecedented fall in the number of women dying from breast cancer has been hailed by scientists.

A drug, tamoxifen, developed in the UK, appears mainly responsible for almost a 30% drop in deaths in the UK over the last decade, reported the Lancet medical journal.

It is the most sudden drop in mortality for a common cancer seen anywhere in the world.

And it reverses a 26% rise in mortality between the 1950s and 1987.

New treatments are now far better at stopping the cancer recurring once the initial malignant breast lump has been removed by surgeons.

But doctors expressed concern that some women who could be helped by improved treatments were still not getting them.


tamoxifen
Tamoxifen works well against some breast cancers
For example, the hormonal therapy tamoxifen, normally given straight after breast surgery, is still not given to many younger women despite evidence that it reduces the chance of recurrence.

Professor Richard Peto, from the Imperial Cancer Research Fund, said: "Starting tamoxifen immediately after breast cancer surgery prevented one in six women from relapsing and one in twelve from dying, irrespective of age.

"But most of the young breast cancer patients who need tamoxifen aren't yet getting it."

Halves rate of return

A study of the drug suggested that starting it immediately after surgery, and continuing the treatment for at least five years, halved the recurrence rate.

Dr Michael Clarke, the study co-ordinator, said: "Tamoxifen is not expensive - in most countries, five years of treatment costs only a few hundred pounds - or, to put it another way, a few thousand pounds per life saved."

David Campbell-Morrison, director of the Campaign for Effective and Rational Treatment, said: "This report underlines what Cert has been consistently telling the government - that proper use of the right drugs, in the right patients at the right time can, and does, save lives.

"This has been achieved even with the older types of chemotherapy. Think what might be possible if the NHS put realistic resources into the newer proven drugs."

Two other pieces of research suggested that both radiotherapy and improvements in chemotherapy were also saving lives.

In addition, the early detection of breast cancers by the national breast screening programme has undoubtedly had a positive impact.

'Good news'

Delyth Morgan, chief executive of the charity Breakthrough Breast Cancer, said: "This is good news for women. Any reduction in the numbers dying from breast cancer is to be welcomed.

"It is still not clear exactly what the causes of the reduction are, but they could be due to a variety of factors including the introduction of chemotherapy, new drug treatments, better surgeons, earlier detection, better diet or a host of other influences."

She said tamoxifen had been a major advance, but added that women should be aware of the risks of taking the drug as well as the benefits.

Other cancers have not seen such a dramatic drop in mortality figures.

Professor Jonathan Waxman said there had been enormous increases in prostate cancer over the last 30 years, with deaths rising from 3,300 in 1964 to 8,600 in 1998.

Despite the increase, only 800,000 has been spent on research in the past three years, compared with 5m a year for breast cancer, he told BBC Radio 4's Today programme

Search BBC News Online

Advanced search options
Launch console
BBC RADIO NEWS
BBC ONE TV NEWS
WORLD NEWS SUMMARY
PROGRAMMES GUIDE
See also:

04 Jan 00 | Health
Cancer rates rising
12 Apr 00 | Health
Breast cancer 'may be blocked'
17 Mar 00 | C-D
Breast Cancer
19 May 00 | Medical notes
Tamoxifen
Internet links:


The BBC is not responsible for the content of external internet sites

Links to more Health stories are at the foot of the page.


E-mail this story to a friend

Links to more Health stories